When was ROCHE DIAGNOSTICS BELGIUM founded?

ROCHE DIAGNOSTICS BELGIUM was founded on 07 Nov 1958, making it 67 years old.

Is ROCHE DIAGNOSTICS BELGIUM still active?

Yes, ROCHE DIAGNOSTICS BELGIUM is currently active.

What does ROCHE DIAGNOSTICS BELGIUM do?

ROCHE DIAGNOSTICS BELGIUM's registered main activity is Wholesale of pharmaceutical and medical goods.

Where is ROCHE DIAGNOSTICS BELGIUM registered?

ROCHE DIAGNOSTICS BELGIUM's registered address is Berkenlaan 8A box 8, 1831 Machelen (Brab.), Belgium.

How many employees does ROCHE DIAGNOSTICS BELGIUM have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), ROCHE DIAGNOSTICS BELGIUM reported 187.3 full-time equivalent employees.

What is ROCHE DIAGNOSTICS BELGIUM's annual turnover?

ROCHE DIAGNOSTICS BELGIUM's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €131,200,707.

Did ROCHE DIAGNOSTICS BELGIUM make a profit or a loss?

ROCHE DIAGNOSTICS BELGIUM's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €1,214,693.

When did ROCHE DIAGNOSTICS BELGIUM last file annual accounts?

ROCHE DIAGNOSTICS BELGIUM's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is ROCHE DIAGNOSTICS BELGIUM B Corp certified?

We have no B Corp certification on file for ROCHE DIAGNOSTICS BELGIUM.

Does ROCHE DIAGNOSTICS BELGIUM hold Fairtrade certification?

No, ROCHE DIAGNOSTICS BELGIUM does not currently hold Fairtrade certification.

ROCHE DIAGNOSTICS BELGIUM

BE 0403.049.945

Copied!

NV/SA

Status

Active

Founded

07 Nov 1958

Size

Large · 187.3 FTE

Age

67 yrs

Main activity

Wholesale of pharmaceutical and medical goods

Activities

1 activity

Wholesale of pharmaceutical and medical goods

Financials

Turnover2025

€131M+1.3%

Profit / Loss2025

€1.2M-38.7%

Equity2025

€36.2M+3.5%

2025	2024	2023	2022
€131,200,707+1.3%	€129,580,139-0.2%	€129,824,389-2.6%	€133,317,620
€1,214,693-38.7%	€1,982,930-42.7%	€3,462,892-10.3%	€3,860,246
€36,166,901+3.5%	€34,952,208+6%	€32,969,278+11.7%	€29,506,386
€26,514,398-1%	€26,777,505+4.4%	€25,662,166-3.4%	€26,556,660
€0	€0-100%	€2,952,596>1000%	€2,087
187.3+1.7%	184.2-1%	186.1+1.1%	184.1
€700,484-0.4%	€703,475+0.8%	€697,606-3.7%	€724,159

Frequently asked questions

01What is ROCHE DIAGNOSTICS BELGIUM's official registered name?

ROCHE DIAGNOSTICS BELGIUM.

02What is ROCHE DIAGNOSTICS BELGIUM's enterprise number (VAT number)?

BE 0403.049.945.

03What is ROCHE DIAGNOSTICS BELGIUM's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€131,200,707+1.3%	€129,580,139-0.2%	€129,824,389-2.6%	€133,317,620
	€27,151,279-3.3%	€28,093,167+16.7%	€24,068,705-2.1%	€24,584,896
	€3,618,865-18.6%	€4,445,183-33.6%	€6,690,853+12.1%	€5,969,718
	€14,385,740+1.7%	€14,152,591-6%	€15,060,451+2.7%	€14,670,218
	€11,908,530+2.5%	€11,622,644-6.3%	€12,409,418+0.4%	€12,362,341
	€1,214,693-38.7%	€1,982,930-42.7%	€3,462,892-10.3%	€3,860,246
	€2,330,743-6.6%	€2,494,471+385.1%	€514,176-71.6%	€1,812,214
Profitability
	11.0%+0.4%	10.9%-5.8%	11.6%+5.4%	11.0%
	0.9%-39.5%	1.5%-42.6%	2.7%-7.9%	2.9%
	3.4%-40.8%	5.7%-46%	10.5%-19.7%	13.1%
	1.9%-39.6%	3.1%-45.5%	5.8%-15%	6.8%
Solvency
	€64,011,224+1.4%	€63,132,675+5%	€60,102,100+5.5%	€56,956,774
	€24,844,431-6.7%	€26,625,205+9.6%	€24,297,261+17.7%	€20,641,613
	€3,490	—	€17,4330%	€17,433
	€36,166,901+3.5%	€34,952,208+6%	€32,969,278+11.7%	€29,506,386
	56.5%+2.1%	55.4%+0.9%	54.9%+5.9%	51.8%
	€26,514,398-1%	€26,777,505+4.4%	€25,662,166-3.4%	€26,556,660
	0.73-4.3%	0.77-1.6%	0.78-13.5%	0.90
	26.20-47.8%	50.22+29.5%	38.80-49.6%	76.93
Liquidity
	€0	€0-100%	€2,952,596>1000%	€2,087
	€8,559,504+35%	€6,340,779+15.4%	€5,492,734+22.6%	€4,479,805
	€29,615,956+10.7%	€26,760,668+11.5%	€24,007,945-19.1%	€29,683,824
	€11,933,548+15.3%	€10,348,063-46.4%	€19,295,309+88.7%	€10,225,265
	€24,459,326-5.6%	€25,901,525+6.7%	€24,275,267-6.8%	€26,038,848
	1.48+13.6%	1.30+7%	1.22-6.1%	1.29
	€12,648,904+57.2%	€8,047,495-5%	€8,475,063+8.3%	€7,826,449
Efficiency
	82 days+9.3%	75 days+11.7%	68 days-16.9%	81 days
	48 days+13.3%	43 days-37.6%	68 days+80.8%	38 days
	40 days+30.8%	31 days+40.1%	22 days+18.9%	19 days
	10.38-18%	12.66-30.5%	18.23-4.6%	19.12
Profit appropriation
	€32,416,566+3.9%	€31,201,566+6.8%	€29,215,566+13.4%	€25,755,566
	€335-47.8%	€642-82.7%	€3,712+352.9%	€819

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€131,200,707+1.3%	€129,580,139-0.2%	€129,824,389-2.6%	€133,317,620
	€27,151,279-3.3%	€28,093,167+16.7%	€24,068,705-2.1%	€24,584,896
	€3,618,865-18.6%	€4,445,183-33.6%	€6,690,853+12.1%	€5,969,718
	€14,385,740+1.7%	€14,152,591-6%	€15,060,451+2.7%	€14,670,218
	€11,908,530+2.5%	€11,622,644-6.3%	€12,409,418+0.4%	€12,362,341
	€1,214,693-38.7%	€1,982,930-42.7%	€3,462,892-10.3%	€3,860,246
	€2,330,743-6.6%	€2,494,471+385.1%	€514,176-71.6%	€1,812,214
Profitability
	11.0%+0.4%	10.9%-5.8%	11.6%+5.4%	11.0%
	0.9%-39.5%	1.5%-42.6%	2.7%-7.9%	2.9%
	3.4%-40.8%	5.7%-46%	10.5%-19.7%	13.1%
	1.9%-39.6%	3.1%-45.5%	5.8%-15%	6.8%
Solvency
	€64,011,224+1.4%	€63,132,675+5%	€60,102,100+5.5%	€56,956,774
	€24,844,431-6.7%	€26,625,205+9.6%	€24,297,261+17.7%	€20,641,613
	€3,490	—	€17,4330%	€17,433
	€36,166,901+3.5%	€34,952,208+6%	€32,969,278+11.7%	€29,506,386
	56.5%+2.1%	55.4%+0.9%	54.9%+5.9%	51.8%
	€26,514,398-1%	€26,777,505+4.4%	€25,662,166-3.4%	€26,556,660
	0.73-4.3%	0.77-1.6%	0.78-13.5%	0.90
	26.20-47.8%	50.22+29.5%	38.80-49.6%	76.93
Liquidity
	€0	€0-100%	€2,952,596>1000%	€2,087
	€8,559,504+35%	€6,340,779+15.4%	€5,492,734+22.6%	€4,479,805
	€29,615,956+10.7%	€26,760,668+11.5%	€24,007,945-19.1%	€29,683,824
	€11,933,548+15.3%	€10,348,063-46.4%	€19,295,309+88.7%	€10,225,265
	€24,459,326-5.6%	€25,901,525+6.7%	€24,275,267-6.8%	€26,038,848
	1.48+13.6%	1.30+7%	1.22-6.1%	1.29
	€12,648,904+57.2%	€8,047,495-5%	€8,475,063+8.3%	€7,826,449
Efficiency
	82 days+9.3%	75 days+11.7%	68 days-16.9%	81 days
	48 days+13.3%	43 days-37.6%	68 days+80.8%	38 days
	40 days+30.8%	31 days+40.1%	22 days+18.9%	19 days
	10.38-18%	12.66-30.5%	18.23-4.6%	19.12
Profit appropriation
	€32,416,566+3.9%	€31,201,566+6.8%	€29,215,566+13.4%	€25,755,566
	€335-47.8%	€642-82.7%	€3,712+352.9%	€819

2025

2024

2023

2022

Income statement

€131,200,707+1.3%

€129,580,139-0.2%

€129,824,389-2.6%

€133,317,620

€27,151,279-3.3%

€28,093,167+16.7%

€24,068,705-2.1%

€24,584,896

€3,618,865-18.6%

€4,445,183-33.6%

€6,690,853+12.1%

€5,969,718

€14,385,740+1.7%

€14,152,591-6%

€15,060,451+2.7%

€14,670,218

€11,908,530+2.5%

€11,622,644-6.3%

€12,409,418+0.4%

€12,362,341

€1,214,693-38.7%

€1,982,930-42.7%

€3,462,892-10.3%

€3,860,246

€2,330,743-6.6%

€2,494,471+385.1%

€514,176-71.6%

€1,812,214

Profitability

11.0%+0.4%

10.9%-5.8%

11.6%+5.4%

11.0%

0.9%-39.5%

1.5%-42.6%

2.7%-7.9%

2.9%

3.4%-40.8%

5.7%-46%

10.5%-19.7%

13.1%

1.9%-39.6%

3.1%-45.5%

5.8%-15%

6.8%

Solvency

€64,011,224+1.4%

€63,132,675+5%

€60,102,100+5.5%

€56,956,774

€24,844,431-6.7%

€26,625,205+9.6%

€24,297,261+17.7%

€20,641,613

€3,490

—

€17,4330%

€17,433

€36,166,901+3.5%

€34,952,208+6%

€32,969,278+11.7%

€29,506,386

56.5%+2.1%

55.4%+0.9%

54.9%+5.9%

51.8%

€26,514,398-1%

€26,777,505+4.4%

€25,662,166-3.4%

€26,556,660

0.73-4.3%

0.77-1.6%

0.78-13.5%

0.90

26.20-47.8%

50.22+29.5%

38.80-49.6%

76.93

Liquidity

€0

€0-100%

€2,952,596>1000%

€2,087

€8,559,504+35%

€6,340,779+15.4%

€5,492,734+22.6%

€4,479,805

€29,615,956+10.7%

€26,760,668+11.5%

€24,007,945-19.1%

€29,683,824

€11,933,548+15.3%

€10,348,063-46.4%

€19,295,309+88.7%

€10,225,265

€24,459,326-5.6%

€25,901,525+6.7%

€24,275,267-6.8%

€26,038,848

1.48+13.6%

1.30+7%

1.22-6.1%

1.29

€12,648,904+57.2%

€8,047,495-5%

€8,475,063+8.3%

€7,826,449

Efficiency

82 days+9.3%

75 days+11.7%

68 days-16.9%

81 days

48 days+13.3%

43 days-37.6%

68 days+80.8%

38 days

40 days+30.8%

31 days+40.1%

22 days+18.9%

19 days

10.38-18%

12.66-30.5%

18.23-4.6%

19.12

Profit appropriation

€32,416,566+3.9%

€31,201,566+6.8%

€29,215,566+13.4%

€25,755,566

€335-47.8%

€642-82.7%

€3,712+352.9%

€819

ROCHE DIAGNOSTICS BELGIUM

Activities

Financials

Frequently asked questions

All locations

All locations